Diamyd Medicals booth at the ADA, American Diabetes Association, continues to be very busy during the second day of the Conference. The Diamyd
® vaccine has become well known and many physicians and scientists are interested to learn more. During the day we had physicians from US and Europe and also from Asia and South America that came to the booth, and interest increased after Dr. Eisenbarths Banting Medal for Outstanding Scientific Achievement Award lecture, where the Diamyd approach was discussed.
Dr. Jerry Palmer, Lead Investigator for the Phase III study in the US, and Peter Zerhouni, Director of Business Development at Diamyd Medical.